Cargando…
Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability
Myelodysplastic syndromes (MDS) are haematopoietic malignancies that are characterised by a heterogeneous clinical course. In recent years, sequencing efforts have uncovered recurrent somatic mutations within RNA splicing factors, including SF3B1, SRSF2, U2AF1 and ZRSR2. The most frequently mutated...
Autores principales: | Liberante, Fabio Giuseppe, Lappin, Katrina, Barros, Eliana M., Vohhodina, Jekaterina, Grebien, Florian, Savage, Kienan I., Mills, Kenneth Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390101/ https://www.ncbi.nlm.nih.gov/pubmed/30804405 http://dx.doi.org/10.1038/s41598-019-39591-7 |
Ejemplares similares
-
The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export
por: Vohhodina, Jekaterina, et al.
Publicado: (2017) -
Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
por: Lappin, Katrina M., et al.
Publicado: (2022) -
Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes
por: Dolatshad, H, et al.
Publicado: (2016) -
Chronic loss of STAG2 leads to altered chromatin structure contributing to de-regulated transcription in AML
por: Smith, James S., et al.
Publicado: (2020) -
let-65 is cytoplasmic methionyl tRNA synthetase in C. elegans
por: Alriyami, Maha Z., et al.
Publicado: (2014)